The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real Risk
Posted: Dec 29th, 2025In: Opinions & FeaturesNew insight from WBB Securities President Dr. Steve Brozak in Forbes. In “The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real Risk,” Steve explores how the potential expiration of enhanced ACA subsidies could[...]
Read More about The U.S. 2026 Healthcare Cliff: When the Business Model Is the Real RiskDiagnosing Medicaid Cuts To Hospitals In The One, Big, Beautiful Bill – Published in Forbes
Posted: Jul 4th, 2025In: Opinions & FeaturesIn his latest Forbes article, WBB Securities President Dr. Steve Brozak examines the hidden dangers behind recent Medicaid funding cuts buried within a sweeping federal spending bill. Titled "Diagnosing Medicaid Cuts To Hospitals In The[...]
Read More about Diagnosing Medicaid Cuts To Hospitals In The One, Big, Beautiful Bill – Published in ForbesPresident Donald Trump – Will He Become the Drug Price Equalizer?
Posted: May 13th, 2025In: Opinions & FeaturesDr. Steve Brozak, President of WBB Securities, has authored a new opinion piece in Forbes
Read More about President Donald Trump – Will He Become the Drug Price Equalizer?
Onshoring Drug Manufacturing Is Critical But Not Easy
Posted: May 5th, 2025In: Opinions & FeaturesWBB Securities is pleased to share a featured interview with our Managing Director, Dr. Steve Brozak, published in The Wall Street Transcript on April 29, 2025.
Read More about Onshoring Drug Manufacturing Is Critical But Not EasyPharma Dodges The Tariff Bullet—But For How Long?
Posted: Apr 3rd, 2025In: Opinions & FeaturesPharmaceutical tariffs are looming again, and the stakes are higher than ever.
Read More about Pharma Dodges The Tariff Bullet—But For How Long?As Tariffs Begin; What Will They Do To Drug Prices And Availability?
Posted: Mar 4th, 2025In: Opinions & FeaturesThe Trump administration just levied tariffs on China, Mexico, and Canada with a message: it’s not about trade, it’s about fentanyl.
Read More about As Tariffs Begin; What Will They Do To Drug Prices And Availability?Is RFK Jr. Just What The Doctor Ordered? 5 Ways He Could Heal Healthcare
Posted: Nov 8th, 2024In: Opinions & FeaturesIs RFK Jr. the answer for U.S. healthcare reform? Dr. Brozak’s Forbes article outlines five key signs that indicate possible major changes under RFK Jr.'s influence.
Read More about Is RFK Jr. Just What The Doctor Ordered? 5 Ways He Could Heal HealthcareLifeline, A Musical That Raises The Alarm On Antimicrobial Resistance
Posted: Sep 24th, 2024In: Opinions & FeaturesThe musical Lifeline not only entertains but educates on one of the greatest health challenges of our time—antimicrobial resistance. This Forbes article explores how the arts and AI-powered diagnostics are raising awareness and driving change.[...]
Read More about Lifeline, A Musical That Raises The Alarm On Antimicrobial Resistance
How Policy Makers Can Act Now To Prevent An Avian Influenza Pandemic / Health Affairs Forefront / Wrote by Rick Bright, Steve Brozak, and Richard A. Marfuggi
Posted: Sep 20th, 2024In: Opinions & FeaturesIt is crucial that we do not continue with a passive, wait-and-see approach, as it is bound to fail. Instead, we must proactively advance a public-private partnership to act now, leveraging public resources, private technology,[...]
Read More about How Policy Makers Can Act Now To Prevent An Avian Influenza Pandemic / Health Affairs Forefront / Wrote by Rick Bright, Steve Brozak, and Richard A. Marfuggi
How Covid-19 Is Still A Big Factor In Presidential Politics
Posted: Jul 22nd, 2024In: Opinions & FeaturesCovid-19 has now contributed to two second-term presidential campaigns. In November 2020, when the virus was raging throughout the world, and fears were at their peak, the country sought a return to normalcy – And[...]
Read More about How Covid-19 Is Still A Big Factor In Presidential Politics